Average Co-Inventor Count = 6.10
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (22 from 3,222 patents)
2. Abbvie Inc. (6 from 822 patents)
3. Hoffmann-la Roche Inc. (4 from 4,945 patents)
4. Walter and Eliza Hall Institute of Medical Research (4 from 80 patents)
5. Abbott Laboratories Corporation (2 from 4,179 patents)
6. F. Hoffmann-la Roche Ag (1 from 168 patents)
7. The Burnham Institute (1 from 94 patents)
22 patents:
1. 12187816 - Macrocyclic compounds and methods of use thereof
2. 11666581 - PROTAC antibody conjugates and methods of use
3. 11590128 - Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
4. 11413282 - Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
5. 11110087 - Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor
6. 10993942 - Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
7. 9539251 - Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor
8. 9067928 - Compounds and methods of use
9. 8980837 - Inhibitors of IAP
10. 8518970 - Compounds and methods of use
11. 8232273 - Heterocyclic compounds and methods of use
12. 8168645 - Arylsulfonamide compounds
13. 8114893 - Compounds and methods of use
14. 8110568 - Inhibitors of IAP
15. 7563583 - Heregulin variants